Largest Verdict in a Personal Injury case
in Pennsylvania history
Largest-ever compensatory verdict
Then-second largest Product
Liability verdict in U.S. history
Auto Accident Verdict
Largest single-victim fatality settlement
Civil Rights verdict
- Click Here For Kline & Specter News Alerts
- Drexel University announces Thomas R. Kline School of Law (click here)
- National Law Journal names Kline & Specter among America's Elite Trial Lawyers (click here)
- 15 at Kline & Specter named Super Lawyers, Rising Stars (click here)
- On TV ⇒ Tom Kline files suit deadly NJ gas explosion - see coverage (click here)
- On TV ⇒ Tom Kline files suit in death of radio host E. Steven Collins (click here)
- On TV ⇒ Specter files suit in fatal fire escape collapse (click here)
- PA Supreme Court to hear Tom Kline appeal on liability cap law (click here)
- Kline, Safier, Clarke win $42.9M med-mal verdict -- one of PA's largest (click here)
- On TV ⇒ Shanin Specter interviewed on house explosion lawsuit (click here)
- Kline, Guerrini, Williams win $11.6M premises liability settlement (click here)
- Study: Kline & Specter tops in major PA verdicts, settlements (click here)
- Kline & Specter had largest award vs. VA in 10 years (click here)
- Kline & Specter settles first Penn State sexual abuse case (click here)
- On TV ⇒ Andy Stern comments on building collapse video (click here)
- On TV ⇒ Kline & Specter files suit in unnecessary stent procedure case
- Firm wins record $105 million settlement in power line death case
- Specter, Baldwin, Guerrini $109 million verdict among U.S.Top 10
- Tom Kline named 2013 Best Philadelphia Medical Malpractice Lawyer
- Seven at Kline & Specter named "Best Lawyers in America"
- Kline & Specter Courtroom dedicated at Penn Law School
- Kline & Specter named No. 1 Product Liability Firm in the United States
- Kline, Specter named among nation's 500 "Leading Lawyers"
- On TV ⇒ ESPN features the Plevretes case, Shanin Specter
- Best Lawyers names Tom Kline No. 1 Phila. personal injury attorney
- Specter, Safier, Williams win $17.5M med-mal verdict
- See more Kline & Specter stories in the news
Dialysis Injury Lawsuits
Pennsylvania - New Jersey - Delaware - New York - Nationwide
Dialysis patients may have suffered cardiac arrest, in some cases fatal episodes, because of a company’s failure to warn doctors about the risk and proper use of a substance used in the blood-cleansing procedure.
The government is investigating whether Fresenius Medical Care violated federal regulations by cautioning its own doctors but not those at other dialysis centers about the potential misuse of Granuflo, which can sharply increase -- by six fold -- cases of sudden death from cardiac arrest.
It was estimated that 941 patients had suffered cardiac arrest at Fresenius clinics alone over a one-year period. Others likely suffered similar incidents at other centers as well as ailments such as heart attacks and stroke, in some cases leading to death.
If you or a loved one suffered severe cardiac arrest related to dialysis, you should contact a dialysis attorney. Kline & Specter, with some 30 attorneys, five of whom are also highly skilled doctors, has the expertise to investigate and litigate dialysis injury cases.
About 400,000 Americans receive dialysis, with Fresenius Medical Care treating about one-third of those patients. The U.S. Food and Drug Administration is investigating whether the company failed to inform customers of the potentially lethal risk of Granuflo.
News reports said that in November 2011 Fresenius sent an internal email warning company-affiliated doctors at its own dialysis centers that the use of Granuflo seemed to be contributing to a large rise in the risk of patients dying suddenly from cardiac arrest during dialysis, but that a similar warning did not go to the FDA, other doctors or consumers. That wider warning was finally sent in March 2012 after the FDA got a copy of the memo. It is estimated that 125,000 patients are treated using Granuflo in non-Fresenius clinics.
Questions have arisen over whether a failure to warn not only put patients at risk but also violated FDA regulations and ethical standards. The internal Fresenius memo, according to news reports, made it apparent the company was aware of the potential danger, citing 941 prior incidents of cardiac arrest in 2010 at Fresenius clinics alone.
How it works: Granuflo, the most widely prescribed dry acid product for dialysis, is used to dissolve acid in the blood. Granuflo contains more of an ingredient than competing products that the body uses to convert to bicarbonate which then neutralizes acid.
Doctors who were unaware of the extra bicarbonate contribution from GranuFlo may have prescribed even more bicarbonates – essentially giving patients an overdose. The resulting excessive levels of alkaline, called metabolic alkalosis, can lead to serious heart problems.